Indeed, GGT1 expression levels were significantly lower in tumors with treatment-induced NEPC (t-NEPC) features and small cell carcinomas (SCC) compared to CRPC-adenocarcinomas (CRPC-Adeno). This evidence concerns the gene GGT1 and adenocarcinoma.